Skip to main content
PMC home page
Diagnostics logoLink to Diagnostics
. 2021 Sep 13;11(9):1667. doi: 10.3390/diagnostics11091667

Absence of Stress Hyperglycemia Indicates the Most Severe Form of Blunt Liver Trauma

Janett Kreutziger 1,*, Margot Fodor 2, Dagmar Morell-Hofert 3, Florian Primavesi 4, Stefan Stättner 4, Eva-Maria Gassner 3, Stefan Schmid 1, Christopher Rugg 1
Editor: Consolato M Sergi
PMCID: PMC8470453  PMID: 34574008

Abstract

Background: Stress hyperglycemia is common in trauma patients. Increasing injury severity and hemorrhage trigger hepatic gluconeogenesis, glycogenolysis, peripheral and hepatic insulin resistance. Consequently, we expect glucose levels to rise with injury severity in liver, kidney and spleen injuries. In contrast, we hypothesized that in the most severe form of blunt liver injury, stress hyperglycemia may be absent despite critical injury and hemorrhage. Methods: All patients with documented liver, kidney or spleen injuries, treated at a university hospital between 2000 and 2020 were charted. Demographic, laboratory, radiological, surgical and other data were analyzed. Results: A total of 772 patients were included. In liver (n = 456), spleen (n = 375) and kidney (n = 152) trauma, an increase in injury severity past moderate to severe (according to the American Association for the Surgery of Trauma, AAST III-IV) was associated with a concomitant rise in blood glucose levels independent of the affected organ. While stress-induced hyperglycemia was even more pronounced in the most severe forms (AAST V) of spleen (median 10.7 mmol/L, p < 0.0001) and kidney injuries (median 10.6 mmol/L, p = 0.004), it was absent in AAST V liver injuries, where median blood glucose level even fell (5.6 mmol/L, p < 0.0001). Conclusions: Absence of stress hyperglycemia on hospital admission could be a sign of most severe liver injury (AAST V). Blood glucose should be considered an additional diagnostic criterion for grading liver injury.

Keywords: stress hyperglycemia, liver injury, kidney injury, spleen injury, trauma, outcome, AAST, blood glucose, diagnostic criterion, parenchymatous organs

1. Introduction

Stress hyperglycemia is common in trauma patients, and critical illness on hospital admission and is often associated with poor outcome [1,2,3,4,5,6,7]. This stress hyperglycemia is caused by neuroendocrine, inflammatory and metabolic responses to trauma-associated stressors. Pain, anxiety and psychogenic stress may lead to activation of the sympathetic nervous system and the hypothalamic–pituitary axis, increasing circulating catecholamines. A traumatic brain injury may even lead to a sympathetic storm [8,9], thus further amplifying this neuroendocrine response. Another very strong trigger for a stress response such as stress hyperglycemia is hemorrhage [10], which is mediated by baroreceptors and multifactorially released cytokines [11]. Furthermore, tissue hypoxemia and injury, endothelial damage and complement activation [12,13] kick off an avalanche of immune-stimulating and -modulating chemokines, interleukins [14,15,16], damage-associated molecular patterns (DAMPS) and multiple cell line activations [13,17]. Circulating and locally secreted tumor necrosis factor (TNF)α [18,19] and catecholamines [20] lead to hepatic insulin resistance, which annuls glucose homeostasis. By triggering rampant hepatic gluconeogenesis and glycogenolysis both processes are decoupled from physiological feedback mechanisms [21,22,23] and, additionally, are fed by free fatty acids released by catecholamines from fat tissue, [24,25] but also from lactate and alanine of muscle tissue [25,26,27].

TNFα-associated hepatic insulin resistance is probably mediated by TNF receptors by activating a kinase (c-Jun-NH2-terminal kinase), which in turn catalyzes serine phosphorylation of insulin receptor substrate 1 (IRS-1). This blocks the phosphatidylinositol 3-kinase (PI3K) and protein kinase B (AKT) pathway of intracellular metabolic effects of insulin [28]. Catecholamine (epinephrine)-mediated insulin resistance is conveyed via 3′–5′-cyclic adenosine monophosphate (cyclic AMP or cAMP) [29], activating protein kinase A (PKA) [30]. On the one hand, phosphorylase kinase is activated, itself stimulating glycogen phosphorylase and therefore leading to a disintegration of glycogen stores and release of glucose [31,32]. On the other hand, PKA inhibits in parallel substrate flux through phosphofructokinase-1 (PFK-1) (rate-limiting enzyme in glycolysis), thereby enhancing the delivery of glucose by the liver [33,34]. Moreover, peripheral insulin resistance—mainly of the muscles and probably by comparable mechanisms—limits glucose uptake and metabolism [21,35].

Probably, the pathophysiological purpose of all these varying responses to trauma is to shift energy substrates to vital organs, initiate immune defense, and repair mechanisms [20,21,22,25,26,36], which can therefore be seen as survival responses. Consequently, according to the literature, hypoglycemia is a rare finding in trauma patients at hospital admission and is triggered mainly by non-traumatic causes, such as anti-diabetic drug overdose, alcohol intoxication or chronic liver disease [37,38]. To date, there has been no consistency in defining blood glucose levels, for which reason this trial refrains from specifying any threshold values for stress hyperglycemia.

Injury severity of parenchymatous organs, such as liver, kidney or spleen, is often radiologically categorized according to the classification of the American Association for the Surgery of Trauma, AAST [39,40], Table 1. In doing so, the extent of lacerations, contusions or hematomas must be exactly measured. However, specifying proportions of parenchymal disruption of one or both hepatic lobes to distinguish between liver injury AAST IV and V may be very challenging. Active bleeding is included in AAST ≥ III injuries of the liver and kidney and AAST ≥ IV injuries of the spleen [39,40]. AAST V injuries of the liver are furthermore defined as major juxtahepatic venous injury (vena cava, central major hepatic veins) or lacerations resulting in parenchymal disruption of more than 75% of one hepatic lobe [39,40]. Assuming the liver is the primary origin of stress hyperglycemia, it seems clear that such destructive liver injuries, partially even resulting in devascularization (inflow or outflow), can impede hepatic glucose liberation provoked by trauma or hemorrhage.

Table 1.

Organ Injury Scale (OIS) of the American Association for Surgery of Trauma (AAST): 2018 revision.

AAST AIS Liver Spleen Kidney
I 2 Hematoma Subcapsular, <10% surface area Subcapsular, <10% surface area Subcapsular hematoma and/or parenchymal contusion without laceration
Laceration Capsular tear, <1% parenchymal depth Capsular tear, <1% parenchymal depth
II 2 Hematoma Subcapsular, 10–50% surface area,
intra-parenchymal, <10 cm in diameter 		Subcapsular, 10–50% surface area
Intra-parenchymal, <5 cm in diameter 		Perirenal hematoma confined to Gerota fascia
Laceration Capsular tear, 1–3 cm parenchymal depth, <10 cm length 1–3 cm parenchymal depth Renal parenchymal laceration ≤1 cm depth without urinary extravasation
III 3 Hematoma Subcapsular, >50% surface area of ruptured subcapsular or parenchymal hematoma; intraparenchymal >10 cm Subcapsular, >50% surface area
Ruptured subcapsular or parenchymal hematoma ≥5 cm
Laceration Capsular tear, >3 cm parenchymal depth >3 cm parenchymal depth or involving trabecular vessels Renal parenchymal laceration >1 cm depth without collecting system rupture or urinary extravasation
Vascular Vascular injury with active bleeding contained within liver parenchyma Any injury in the presence of a kidney vascular injury or active bleeding contained within Gerota fascia
IV 4 Laceration Parenchymal disruption involving 25–75% of hepatic lobe or 1–3 segments Parenchymal laceration involving segmental or hilar vessels producing >25% devascularization Parenchymal laceration extending into urinary collecting system with urinary extravasation
Renal pelvis laceration and/or complete ureteropelvic disruption
Vascular Vascular injury with active bleeding breaching the liver parenchyma into the peritoneum Any injury in the presence of a splenic vascular injury or active bleeding confined within splenic capsule Segmental renal vein or artery injury
Active bleeding beyond Gerota fascia into the retroperitoneum or peritoneum
Segmental or complete kidney infarction(s) due to vessel thrombosis without active bleeding
V 5 Laceration Parenchymal disruption involving >75% of hepatic lobe Shattered spleen Shattered kidney with loss of identifiable parenchymal renal anatomy
Vascular Juxtavenous hepatic injuries; i.e., retrohepatic vena cava/central major hepatic veins Any injury in the presence of splenic vascular injury with active
bleeding extending beyond the spleen into the peritoneum 		Main renal artery or vein laceration or avulsion of hilum
Devascularized kidney with active bleeding
Open in a new tab

Additional points: Advance one grade for multiple injuries up to Grade III. Vascular injury (i.e., pseudoaneurysm or AV fistula) appears as a focal collection of vascular contrast that decreases in attenuation on delayed images. Active bleeding: focal or diffuse collection of vascular contrast that increases in size or attenuation in a delayed phase. Details from [40,41].

Consequently, it was hypothesized that parallel to injury severity and extent of hemorrhage in hepatic, renal or splenic injuries, blood glucose levels should increase and therefore lead to significant stress hyperglycemia. However, it was also hypothesized that in the case of most severe liver injuries (AAST V), defined as major devascularization (inflow or outflow) and/or parenchymal disruption of more than 75% of one hepatic lobe, hepatic gluconeogenesis and glycogenolysis may become insufficient, consequently leading to absence of stress hyperglycemia. This may be a leading diagnostic mark.

2. Materials and Methods

The study was reviewed and approved by the Ethics Committee of the Medical University of Innsbruck (EK 1394/2020), and written informed consent was waived due to the observational character of the study.

This single-center analysis of detailed medical information on hepatic, splenic and renal injuries was performed by searching the local hospital information system (Krankenhausinformationssystem i.s.h.med PowerChart by Cerner Österreich GmbH, Vienna, Austria), which is prospectively maintained and auditable. A pre-existing register developed over a 17-year period (2000–2016) for the analysis of treatment strategies and associated outcomes in blunt liver, spleen and kidney injuries [41,42] was expanded up to 2020, extended to include blood glucose values on hospital admission and re-analyzed with different inclusion and exclusion criteria (Figure 1).

Figure 1.

Figure 1

Open in a new tab

CONSORT flow diagram of patient population.

All trauma patients with suspected blunt hepatic, splenic or renal injury, treated at Innsbruck Medical University Hospital between 1 January 2000 and 31 August 2020 (inclusion criteria) were analyzed regarding stress hyperglycemia as a function of injury severity.

Beside the above-mentioned inclusion criteria, the following exclusion criteria were applied: missing blood glucose levels within the first hour following hospital admission, insufficient documentation of radiologic findings or laboratory analyses regarding the scientific question, admission more than 12 h beyond trauma, death on arrival and hemorrhages due to innate malformations (Figure 1).

Patients transferred from district hospitals to our Level 1 trauma center after receiving diagnostics only and within the 12-h timeframe were also included. Patients with diabetes mellitus were included. All patients underwent either selective abdominal/thoracic/cranial or whole body dual or triple phase computed tomography (CT) scans. CT images were re-evaluated for trial purposes regarding injury grading by two trained radiologists using our picture archiving and communication system (AGFA IMPAX; AGFA Health Care, Greenville, SC, USA).

Injury scoring was performed on the basis of the AAST classification for blunt liver, spleen or kidney trauma in all patients who suffered injuries to at least one of these organs and, additionally, in patients who suffered injuries to one of these organs but excluding severe co-injuries classified as Abbreviated Injury Scale (AIS) 4–6 [43] in any other organ or organ system. This was done to demonstrate the independent effects of particular organ injuries on blood glucose levels.

Primary outcome parameter was the admission blood glucose level depending on severity of injury (AAST I to V) to liver, spleen, and kidney. Secondary outcome parameters were admission blood glucose levels additionally depending on the existence of diabetes mellitus and severe co-injuries (AIS 4–6).

Descriptive statistical analysis was performed and reported proportions (%) and medians with range due to non-normal distribution of data (Shapiro–Wilk test). Overall distribution of blood glucose within the subgroups with and without co-injuries (AIS 4–6) as well as with and without diabetes mellitus was analyzed with the Kruskal–Wallis test. Within-subgroup differences (e.g., between AAST IV and V) were analyzed with the Mann–Whitney U test. Because of the small subgroups, two-tailed p values lower than 0.05 were accepted as significance level throughout the study. The confidence intervals were defined as 95% CI, accordingly. Data analysis was performed with SPSS 26.0 (IBM Corporation, Armonk, NY, USA).

3. Results

3.1. Study Population

During the study period, 879 patients presenting at our Level 1 trauma center with suspected hepatic, splenic or renal injury were assessed for eligibility. Following application of inclusion and exclusion criteria 772 patients, comprising 456 liver, 375 spleen and 152 kidney injuries, were ultimately included in the study; 189 patients had more than one organ injured (Figure 1). Median age was 29 (1–89) years, 238 (31%) patients were female. During hospitalization, 26 (3.4%) patients deceased (Table 2).

Table 2.

Study population characteristics, n = 772.

Characteristics Median/Number Range/Percent
Age 29 1–89
female/male 238/534 30.8/69.2
Body mass index (BMI) 23.0 13.1–43.2
Deceased 26 3.4
Hospital length of stay (d) 13 0–112
Blood glucose (mmol/L) 1 7.16 2.33–27.19 1
ISS 2 21 1–75
Accident mechanism
 Accidents with skis, sleigh, or snowboard 301 39.0
 Accident with motor vehicle 148 19.2
 Accident with moped or motorbike 81 10.5
 Accident with bike, scooter, skateboard 71 9.2
 Fall > 3 m 67 8.7
 Occupational injury 28 3.7
 Unknown mechanism 19 2.5
 Accident with large animal 18 2.3
 Accident as pedestrian 14 1.8
 Fall < 3 m 11 1.4
 Accident with flex wing, parachute or similar 6 0.8
 Fall down stairs 5 0.6
 Brawl 3 0.4
Co-morbidities
 Arterial hypertension 36 4.7
 Other disease 35 4.5
 Psychiatric disease 25 3.2
 Allergy/atopic dermatitis 22 2.8
 Neurologic disease 18 2.3
 Cardiac insufficiency and other cardiac diseases 16 2.1
 Diabetes mellitus 13 1.7
 Alcohol abuse 14 1.8
 Adiposity 12 1.6
 Endocrinologic disease 11 1.4
 Malign disease 10 1.3
 Chronic obstructive pulmonary disease 8 1.0
 Renal insufficiency 8 1.0
 Autoimmune disease 8 1.0
 Metabolic disease 6 0.8
 Coronary heart disease 5 0.6
 Bronchial asthma 5 0.6
Laboratory findings 1
Hemoglobin mg/dL 121 34–187
Thrombocytes G/L 198 14–835
Leukocytes G/L 13.1 1.5–39.1
Lactate mg/dL 15.4 4–176
pH 7.367 6.882–7.642
Bicarbonate standardized mmol/L 22.1 8.3–27.0
Base excess mmol/L −2.0 −15.6–11.0
Potassium mmol/L 3.8 2.32–7.62
Anion gap mmol/L 21.8 8.3–27.0
Open in a new tab

1 Measured within first hour following admission; 2 Injury Severity Score [44].

Compared to the 772 included patients, the 107 excluded patients had a comparable median age (31 (interquartile range: 16–43) years) and gender distribution (31.8% female). Of them, 50 (46.8%) suffered from hepatic, 45 (42.1%) from spleen, and six (6.6%) patients from renal injury. In sum, 13 (12.1%) patients deceased during in-hospital stay. As depicted in Figure 1, nine patients were excluded due to malformation, missing confirmation of the suspected injury or no trauma. In sum, aside from an increased—mainly early—mortality rate, the excluded population is comparable to the included population. Therefore, it was concluded that the included population is representative and inclusion of the excluded population would not have a significant impact on the presented results. Pancreatic injuries were rare in this population. Merely eight patients suffered from concomitant pancreatic injury: five pancreatic contusions were treated conservatively and three pancreatic ruptures were in need of surgical intervention. One segment resection, one surgical closure of the rupture and one complete pancreas resection were performed. Severe pancreatic involvement was mainly concomitant to liver injuries. Blood glucose differed widely and independently of the extent of pancreatic injury, namely from 5.05 to 24.81 mmol/L. Based on the limited number of those affected, the authors could not conclude that pancreatic injuries had a relevant impact on initial blood glucose in this patient population.

3.2. Liver Injuries

We found 456 patients with liver injuries; they were classified as 80 patients with AAST I, 125 patients with AAST II, 176 patients with AAST III, 64 patients with AAST IV, and 11 patients with AAST V. Overall distribution of median blood glucose levels among groups AAST I to V, differed highly significantly (Figure 2). Initial blood glucose levels increased highly significantly from 6.58 mmol/L (4.50–24.64 mmol/L) in patients with AAST I injuries to 8.60 mmol/L (5.55–27.19 mmol/L) in patients with AAST IV injuries (p < 0.0001). In patients with AAST V injuries, median initial blood glucose dropped to 5.77 mmol/L (2.33–7.83 mmol/L), which was significantly lower than in AAST I (p = 0.01) and IV injuries (p < 0.0001) (Figure 2a).

Figure 2.

Figure 2

Open in a new tab

Rising blood glucose levels in parallel to severity of liver injury with lowest blood glucose levels in patients with most severe liver injury (AAST V). Outliers of high blood glucose levels in less severe injuries (AAST I–III) were found in patients with diabetes mellitus disease or severe co-injuries (AIS 4–6) (a–c). In patients without severe co-injuries and without diabetes mellitus (d), the effect of injury severity and hemorrhage on blood glucose levels was demonstrated, meaning the greater the severity of injury and the hemorrhage extent, the higher the stress hyperglycemia. In patients with most severe liver injury (AAST V), stress hyperglycemia is absent. AAST: American Association for the Surgery of Trauma [27,28]; AIS: Abbreviated Injury Scale [43].

Exclusion of patients with diabetes mellitus (n = 6) resulted in very similar results (Figure 2b). Exclusion of patients with severe co-injuries (AIS 4–6, n = 200) (Figure 2c) and, additionally, patients with diabetes mellitus (Figure 2d) demonstrated more clearly the effects of injury severity on blood glucose levels (Table 3).

Table 3.

Blood glucose levels in mmol/L for liver, spleen and kidney injuries as function of injury severity with and without co-injuries AIS 4–6 and diabetes mellitus.

AAST I AAST II AAST III AAST IV AAST V p AAST I AAST II AAST III AAST IV AAST V p
Liver All patients with liver injuries Patients with liver injuries without co-injuries AIS 4–6
Median 6.58 6.88 6.94 8.60 5.77 <0.0001 6.16 6.22 6.41 8.96 5.58 <0.0001
Min-max 4.50–24.64 4.33–22.42 3.77–16.32 5.55–27.19 2.33–7.83 4.50–15.26 4.33–9.05 3.77–14.87 5.55–27.19 3.83–6.94
IQR 5.70–7.95 5.77–8.21 6.05–8.12 7.31–10.91 4.36–6.33 5.63–6.63 5.34–7.44 5.87–7.56 7.99–11.20 5.01–6.06
CI 95% 6.90–8.39 7.05–8.04 7.11–7.71 8.82–10.80 4.32–6.29 5.90–7.12 6.15–6.71 6.54–7.19 9.07–11.75 4.71–6.28
Patients with liver injuries without diabetes mellitus Patients with liver injuries without co-injuries AIS 4–6 without diabetes mellitus
Median 6.52 6.80 6.94 8.52 5.77 <0.0001 6.08 6.22 6.41 8.91 5.58 <0.0001
Min-max 4.50–24.64 4.33–22.42 3.77–16.32 5.55–27.19 2.33–7.83 4.50–7.77 4.33–9.05 3.77–14.87 5.55–27.19 3.83–6.94
IQR 5.67–7.83 5.77–8.21 6.05–8.13 7.17–10.75 4.36–6.33 5.58–6.59 5.37–7.44 5.87–7.56 7.88–11.07 5.01–6.06
CI 95% 6.77–8.24 7.04–8.04 7.11–7.71 8.59–10.36 4.42–6.19 5.85–6.40 6.14–6.70 6.54–7.19 8.75–11.15 4.71–6.28
Spleen All patients with spleen injuries Patients with spleen injuries without co-injuries AIS 4–6
Median 7.13 6.88 7.08 8.32 10.71 <0.0001 6.72 6.55 6.88 8.21 9.41 <0.0001
Min-max 4.83–24.81 3.88–24.25 4.83–13.10 5.05–22.42 5.61–18.48 4.83–9.43 4.83–21.48 4.83–10.32 5.05–13.65 5.61–12.43
IQR 5.90–8.57 5.80–8.69 6.10–8.03 6.94–9.55 9.16–12.43 5.83–7.49 5.72–7.38 5.88–7.44 6.91–9.42 7.42–11.17
CI 95% 6.98–8.39 7.17–8.58 6.96–7.46 8.23–9.92 9.74–12.16 6.34–7.28 6.18–7.97 6.58–7.07 7.96–8.61 8.09–10.40
Patients with spleen injuries without diabetes mellitus Patients with spleen injuries without co-injuries AIS AIS 4–6without diabetes mellitus
Median 6.99 6.88 7.10 8.32 10.60 <0.0001 6.66 6.49 6.88 8.21 9.41 <0.0001
Min-max 4.83–12.71 3.88–24.25 4.83–13.10 5.05–22.42 5.61–18.09 4.83–9.43 4.83–9.60 4.83–10.32 5.05–13.65 5.61–12.43
IQR 5.88–8.30 5.80–8.69 6.10–8.05 6.94–9.55 8.91–11.58 5.83–7.38 5.72–7.30 5.88–7.44 6.91–9.42 7.42–11.17
CI 95% 6.88–7.41 7.13–8.39 6.96–7.46 8.23–9.29 9.74–12.16 6.27–7.19 6.23–7.10 6.58–7.07 7.72–8.85 8.09–10.40
Kidney All patients with kidney injuries Patients with kidney injuries without co-injuries AIS 4–6
Median 6.49 8.21 7.60 8.02 9.60 0.006 6.02 7.44 6.94 8.10 9.10 0.0009
Min-max 5.27–11.16 4.94–24.81 5.11–24.25 5.44–19.59 8.88–18.48 5.27–9.60 5.94–11.99 5.11–12.54 6.05–19.59 8.88–10.60
IQR 5.88–8.27 6.44–11.16 6.55–8.88 6.94–9.84 8.94–10.48 5.66–7.21 6.33–7.88 5.88–7.60 6.98–10.05 8.99–9.85
CI 95% 6.52–7.85 7.35–11.27 7.26–9.24 7.87–9.36 8.29–13.73 5.87–7.30 6.67–8.16 6.45–7.81 7.82–9.80 8.66–10.39
Patients with kidney injuries without diabetes mellitus Patients with kidney injuries without co-injuries AIS 4–6without diabetes mellitus
Median 6.49 7.94 7.60 7.99 9.10 0.02 6.02 7.44 6.94 8.10 9.10 0.001
Min-max 5.27–11.16 4.94–22.42 5.11–24.25 5.44–13.62 8.88–10.60 5.27–9.60 5.94–11.99 5.11–12.54 6.05–11.54 8.88–10.60
IQR 5.88–8.27 6.44–11.04 6.55–8.88 6.94–9.60 8.88–10.10 5.66–7.21 6.33–7.88 5.88–7.60 6.97–9.91 8.99–9.85
CI 95% 6.52–7.85 8.14–10.62 7.26–9.24 7.77–8.99 7.06–11.97 5.87–7.30 6.67–8.16 6.45–7.81 7.76–9.06 8.66–10.39
Open in a new tab

CI: Confidence interval; range: minimum and maximum; IQR: interquartile range.

Of 11 patients with AAST V injuries, only two deceased: one due to uncontrollable bleeding of the liver and partial avulsion of the inferior vena cava, one due to uncontrollable bleeding of the liver and multiple fractures to the pelvis. Of the nine surviving patients with AAST V injury, only one required glucose administration to maintain physiological blood glucose levels during the days subsequent to admission. This was a 13-year-old child, who also needed repeated administration of coagulation factors. In all other patients, blood glucose levels improved over time without additional glucose administration. In patients with initially low or very low (hypoglycemic) blood glucose levels, blood glucose levels recovered spontaneously to slightly increased blood glucose levels following severe trauma. Apparently, the residual hepatic tissue was able to cover physiologic needs, but needed several hours to adapt. Nevertheless, the relatively low blood glucose levels were of high diagnostic importance.

3.3. Spleen Injuries

We found 375 patients with spleen injuries; they were graded as 62 patients with AAST I, 83 patients with AAST II, 142 patients with AAST III, 59 patients with AAST IV, and 29 patients with AAST V injuries. Overall distribution of median blood glucose levels among groups AAST I to V differed highly significantly (Figure 3). Initial blood glucose levels rose highly significantly from 7.13 mmol/L (4.83–24.81 mmol/L) in patients with AAST I to 10.71 mmol/L (5.61–18.48 mmol/L) in patients with AAST V injuries. Initial blood glucose in patients with AAST V injuries rose comparably; there was no drop (Figure 3a). Exclusion of patients with diabetes mellitus (n = 6) resulted in very similar results (Figure 3b). Exclusion of patients with severe co-injuries (AIS 4–6, n = 163) (Figure 3c) and, additionally, patients with diabetes mellitus (Figure 3d) eliminated outliers and demonstrated more clearly that initial blood glucose rose continuously with rising severity of injury and blood loss. Blood glucose in patients with AAST IV and AAST V injuries of the spleen differed highly significantly from that of patients with AAST I injuries (Figure 3c,d, Table 3).

Figure 3.

Figure 3

Open in a new tab

Rising blood glucose levels parallel to injury severity and hemorrhage in splenic injuries. Outliers of very high blood glucose levels in less severe injuries (AAST I-III) were found in patients with diabetes mellitus disease or severe co-injuries (AIS 4–6) (a–c). In patients without severe co-injuries and without diabetes mellitus (d), the effect of injury severity and hemorrhage on blood glucose levels was demonstrated more clearly, meaning the greater the severity of injury and the hemorrhage extent, the higher the stress hyperglycemia including most severe splenic injuries (AAST V). AAST: American Association for the Surgery of Trauma [27,28]; AIS: Abbreviated Injury Scale [43].

3.4. Kidney Injuries

Kidney injuries were far more seldom. Overall, 152 patients were analyzed; they were graded as 21 patients with AAST I, 36 patients with AAST II, 41 patients with AAST III, 48 patients with AAST IV, and six patients with AAST V injuries. Overall distribution of median blood glucose levels among groups AAST I to V differed significantly. Initial blood glucose levels rose highly significantly from 6.49 mmol/L (5.27–11.16 mmol/L) in patients with AAST I to 9.60 mmol/L (8.88–18.48 mmol/L) in patients with AAST V injuries. There was no drop in median initial blood glucose in patients with AAST V injuries (Figure 4a). Exclusion of patients with diabetes mellitus (n = 3) resulted in similar results (Figure 4b). Exclusion of patients with severe co-injuries (AIS 4–6, n = 73) (Figure 4c) and patients with diabetes mellitus (Figure 4d) demonstrated more clearly that initial blood glucose rose continuously with rising severity of injury and blood loss. Blood glucose in patients with AAST IV and AAST V injuries of the kidney differed highly significantly from that of patients with AAST I injuries (Figure 4c,d, Table 3).

Figure 4.

Figure 4

Open in a new tab

Rising blood glucose levels parallel to injury severity in renal injuries. Outliers of very high blood glucose levels in less severe injuries (AAST I-III) were found in patients with diabetes mellitus disease or severe co-injuries (AIS 4–6) (a–c). In patients without severe co-injuries and without diabetes mellitus (d), the effect of injury severity and hemorrhage on blood glucose levels was demonstrated more clearly, meaning the greater the severity of injury and the hemorrhage extent, the higher the stress hyperglycemia including most severe renal injuries (AAST V). AAST: American Association for the Surgery of Trauma [27,28]; AIS: Abbreviated Injury Scale [43].

4. Discussion

The results of this single-center trial demonstrate that stress hyperglycemia develops parallel to injury severity in patients with blunt spleen or kidney trauma. While consistent results were obtained for blood glucose levels in blunt liver injuries up to AAST IV, stress hyperglycemia was completely absent in the most severe cases of liver injury (AAST V), which is demonstrated in this trial for the first time.

Both a pre-diagnosed diabetes mellitus and severe co-injuries (AIS 4–6) resulted in outliers of high blood glucose levels in all grades of injury severity for all three analyzed organ injuries (Figure 2, Figure 3 and Figure 4). However, they had no impact on the main results. Therefore, we did not exclude them from analysis as we felt they realistically represent the expectable extent of clinical settings. Stress hyperglycemia is a common finding in any grade of trauma severity and increases with rising severity [45,46,47,48,49]. This trial demonstrates that also in blunt, single or combined injuries to parenchymatous organs, such as liver, spleen or kidney, stress hyperglycemia accrues with the increasing extent of tissue damage and hemorrhage, thereby proving the thesis of evolution of stress hyperglycemia following trauma as set forth in the Introduction. The finding that severe co-injuries (AIS 4–6) and a pre-diagnosed diabetes mellitus increase the extent of stress hyperglycemia in some patients is also in accordance with the current literature: Rau as well as Kerby and colleagues demonstrated that stress-induced hyperglycemia exists parallel with diabetic hyperglycemia in trauma patients, but is more associated with mortality [50,51,52].

In the literature, the kidneys are also seen as a relevant source of blood glucose production (up to 40% of circulating blood glucose) following epinephrine stimulation [53,54]. Although the body’s own catecholamines should be relevantly increased during severe hemorrhage, which is a criterion for AASTV liver injury, blood glucose dropped in these patients and was not increased by renal glucose delivery. Possible attempts to explain this phenomenon include insufficient renal perfusion during hemorrhagic shock as well as mere lack of time or substances (glutamine, glycerol, lactate) for sufficient renal glucose production. In particular, circulating glutamine is mainly provided by the liver and, therefore, in the event of AAST V injury of the liver, probably lacking.

This study has several limitations. The study did not differentiate between adults, children and diabetics. We did not find significant differences between adults and children, probably due to the low median age of analyzed patients. Pre-hospital vital parameters were not sufficiently documented within the digitalized local hospital information system during the initial decade of the study phase. Therefore, detailed calculation of trauma scores was not possible. Further limitations of this study are the single-center and register design as well as the small patient number in certain subgroups. Nevertheless, this large database of patients with blunt hepatic, splenic, and renal injuries sufficiently demonstrated significant results, especially regarding median blood glucose drop in most severe liver injuries (AAST V). Furthermore, we did not analyze lactatemia due to unreliability of initial laboratory results on hospital admission [10]. Lactatemia is influenced by circulation, production, metabolism and volume resuscitation as well as administration (Ringer’s lactate), if applicable.

Therefore, initial laboratory results may fundamentally vary, not always reflecting severity of injury and hemorrhage. In contrast, blood glucose levels on hospital admission seem to be independent of pre-hospital fluid and volume administration and a reliable, additional diagnostic tool for rapid evaluation of trauma patients including patients with blunt abdominal trauma without collinearity to vital or laboratory parameters commonly used for initial trauma assessment [10]. In the case of hyperglycemia, the extent correlates with injury severity. However, in the case of a critically injured patient presenting with low blood glucose levels, it should be clarified whether—in addition to most severe liver injuries—anti-diabetic drug overdose, alcohol abuse, severe hypothermia or any other reason for limited liver function could be causative [37,55,56]. Furthermore, to distinguish between severe AAST IV and AAST V injuries of the liver—e.g., for scientific purposes—which can be challenging for surgeon or radiologists, glucose measurement may be helpful.

Future prospective studies or registers should confirm the findings of this trial. More studies on the evolution of stress hyperglycemia, its detailed effects on outcome of patients with sepsis or trauma and potential treatment options to limit the well-described negative outcome association are necessary.

5. Conclusions

Absence of stress hyperglycemia on hospital admission could be a sign of most severe liver injury (AAST V). Blood glucose should be considered as an additional diagnostic criterion for grading liver injury.

Acknowledgments

The authors Janett Kreutziger and Margot Fodor contributed equally as first authors.

Author Contributions

Conceptualization, J.K. and S.S. (Stefan Schmid); methodology, J.K. and S.S. (Stefan Stättner); validation, J.K., C.R. and S.S. (Stefan Schmid); formal analysis, J.K.; investigation and resources, M.F., F.P. and S.S. (Stefan Stättner); radiology data investigation and curation, D.M.-H. and E.-M.G.; data curation, J.K.; writing—original draft preparation, J.K. and C.R.; writing—review and editing, all authors; visualization, J.K.; supervision, J.K. and C.R.; project administration, M.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Approval for this trial was obtained from the Ethics Committee of the Medical University of Innsbruck (EK 1394/2020, 12 February, 2021) and the trial was conducted according to the guidelines of the Declaration of Helsinki.

Informed Consent Statement

The manuscript does not contain any patient’s personal data. All data used in this analysis were anonymized and thus the Ethics Committee withdrew the requirement for patients or next of kin to consent to participation in the trial.

Data Availability Statement

All data that support the findings of this study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors have no conflict of interests to declare.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Mamtani M., Kulkarni H., Bihari S., Prakash S., Chavan S., Huckson S., Pilcher D. Degree of Hyperglycemia Independently Associates With Hospital Mortality and Length of Stay in Critically Ill, Nondiabetic Patients: Results From the ANZICS CORE Binational Registry. J. Crit. Care. 2020;55:149–156. doi: 10.1016/j.jcrc.2019.11.003. [DOI] [PubMed] [Google Scholar]
  • 2.Kreutziger J., Schmid S., Umlauf N., Ulmer H., Nijsten M.W., Werner D. Association between Blood Glucose and cardiac Rhythms during pre-hospital care of Trauma Patients—A retrospective Analysis. Scand. J. Trauma Resusc. Emerg. Med. 2018;26:58. doi: 10.1186/s13049-018-0516-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kreutziger J., Lederer W., Schmid S., Ulmer H., Wenzel V., Nijsten M.W., Werner D., Schlechtriemen T. Blood glucose concentrations in prehospital trauma patients with traumatic shock. A retrospective analysis. Eur. J. Anaesthesiol. 2018;35:33–42. doi: 10.1097/EJA.0000000000000733. [DOI] [PubMed] [Google Scholar]
  • 4.Vogelzang M., Nijboer J.M., van der Horst I.C., Zijlstra F., ten Duis H.J., Nijsten M.W. Hyperglycemia Has a Stronger Relation with Outcome in Trauma Patients Than in Other Critically Ill Patients. J. Trauma. 2006;60:873–877. doi: 10.1097/01.ta.0000195715.63978.80. [DOI] [PubMed] [Google Scholar]
  • 5.Bilotta F., Caramia R., Paoloni F.P., Delfini R., Rosa G. Safety and Efficacy of Intensive Insulin Therapy in Critical Neurosurgical Patients. Anesthesiology. 2009;110:611–619. doi: 10.1097/ALN.0b013e318198004b. [DOI] [PubMed] [Google Scholar]
  • 6.Capes S.E., Hunt D., Mamberg K., Pathak P., Gerstein H.C. Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview. Stroke. 2001;32:2426–2432. doi: 10.1161/hs1001.096194. [DOI] [PubMed] [Google Scholar]
  • 7.Capes S.E., Hunt D., Malmberg K., Gerstein H.C. Stress Hyperglycaemia and Increased Risk of Death After Myocardial Infarction in Patients with and without Diabetes: A Systematic Overview. Lancet. 2000;355:773–778. doi: 10.1016/S0140-6736(99)08415-9. [DOI] [PubMed] [Google Scholar]
  • 8.Di Battista A.P., Rhind S.G., Hutchison M.G., Hassan S., Shiu M.Y., Inaba K., Topolovec-Vranic J., Capone Neto A., Rizoli S.B., Baker A.J. Inflammatory cytokine and chemokine profils are associated with patient outcome and the hyperadrenergic state following acute brain injury. J. Neuroinflamm. 2016;13:40. doi: 10.1186/s12974-016-0500-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schöning B., Glöckner F., Lanksch W.R., Volk H.D., Döcke W.D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 1998;4:808–813. doi: 10.1038/nm0798-808. [DOI] [PubMed] [Google Scholar]
  • 10.Kreutziger J., Rafetseder A., Mathis S., Wenzel V., El Attal R., Schmid S. Admission blood glucose predicted haemorrhagic shock in multiple trauma patients. Injury. 2015;46:15–20. doi: 10.1016/j.injury.2014.09.018. [DOI] [PubMed] [Google Scholar]
  • 11.Xu J., Kim H.T., Ma Y., Zhao L., Zhai L., Kokorina N., Wang P., Messina J.L. Trauma and Hemorrhage-Induced Acute Hepatic Insulin Resistance: Dominant Role of Tumor Necrosis Factor (TNF)-alpha. Endocrinology. 2008;149:2369–2382. doi: 10.1210/en.2007-0922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Burk A.M., Martin M., Flierl M.A., Rittirsch D., Helm M., Lampl L., Bruckner U., Stahl G.L., Blom A.M., Perl M., et al. Early complementopathy after multile injuries in humans. Shock. 2012;37:348–354. doi: 10.1097/SHK.0b013e3182471795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Huber-Lang M., Lambris J.D., Ward P.A. Innate immune responses to trauma. Nat. Immunol. 2018;19:327–341. doi: 10.1038/s41590-018-0064-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Roberts D.J., Jenne C.N., Léger C., Kramer A.H., Gallagher C.N., Todd S., Parney I.A., Doig C.J., Yong V.W., Kubes P., et al. Association between the cerebral inflammatory and matrix metalloproteinase responses after severe traumatic brain injury in humans. J. Neurtrauma. 2013;30:1727–1736. doi: 10.1089/neu.2012.2842. [DOI] [PubMed] [Google Scholar]
  • 15.Gentile L.F., Cuenca A.G., Vanzant E.L., Efron P.A., McKinley B., Moore F., Moldawer L.L. Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? Methods. 2013;61:3–9. doi: 10.1016/j.ymeth.2013.04.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Meade P., Shoemaker W.C., Donnelly T.J., Abraham E., Jagels M.A., Cryer H.G., Hugli T.E., Bishop M.H., Wo C.C. Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J. Trauma. 1994;36:651–657. doi: 10.1097/00005373-199405000-00009. [DOI] [PubMed] [Google Scholar]
  • 17.McDonald B., Poittman K., Menezes G.B., Hirota S.A., Slaba I., Waherhouse C.C.M., Beck P.L., Muruve D.A., Kubes P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science. 2010;330:362–366. doi: 10.1126/science.1195491. [DOI] [PubMed] [Google Scholar]
  • 18.Chen X.-L., Sun L., Guo F., Wang F., Liu S., Liang X., Wang R.-S., Wang Y.-J., Sun Y.-X. High-mobility group box-1 induces proinflammatory cytokines production of Kupffer cells through TLRs-dependent signaling pathway after burn injury. PLoS ONE. 2012;7:e50668. doi: 10.1371/journal.pone.0050668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Thobe B.M., Frink M., Hildebrand F., Schwacha M.G., Hubbard W.J., Choudhry M.A., Chaudry I.H. The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage. J. Cell Physiol. 2007;210:667–675. doi: 10.1002/jcp.20860. [DOI] [PubMed] [Google Scholar]
  • 20.Hodis J., Kutinová-Canovà N., Potmĕšsil P., Kameníková L., Kmoníčková E., Zídek Z., Farghali H. The Role of Adrenergic Agonists on Glycogenolysis in Rat Hepatocyte Cultures and Possible Involvement of NO. Physiol. Res. 2007;56:419–425. doi: 10.33549/physiolres.931023. [DOI] [PubMed] [Google Scholar]
  • 21.Li L., Thompson L.H., Zhao L., Messina J.L. Tissue Specific Difference in the Molecular Mechanisms for the Development of Acute Insulin Resistance Following Injury. Endocrinology. 2009;150:24–32. doi: 10.1210/en.2008-0742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.McCowen K.C., Ling P.R., Ciccarone A., Mao Y., Chow J.C., Bistrian B.R., Smith R.J. Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit. Care Med. 2001;29:839–846. doi: 10.1097/00003246-200104000-00032. [DOI] [PubMed] [Google Scholar]
  • 23.Leclercq I.A., Da Silva Morais A., Schroyen B., Van Hul N., Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences. J. Hepatol. 2007;47:142–156. doi: 10.1016/j.jhep.2007.04.002. [DOI] [PubMed] [Google Scholar]
  • 24.Penn A.H., Schmid-Schönbein G.W. The intestine as source of cytotoxic mediators in shock. Free fatty acis and degradation of lipid-binding proteins. Am. J. Physiol. Heart Circ. Physiol. 2008;294:H1779–H1792. doi: 10.1152/ajpheart.00902.2007. [DOI] [PubMed] [Google Scholar]
  • 25.Chu C.A., Galassetti P., Igawa K., Sindelar A.K., Neal D.W., Burish M., Cherrington A.D. Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 2003;284:291–301. doi: 10.1152/ajpendo.00565.2001. [DOI] [PubMed] [Google Scholar]
  • 26.Chu C.A., Sindelar D.K., Neal D.W., Cherrington A.D. Portal adrenergic blockade does not inhibit the gluconeogenetic effects of circulating chatecholamines on the liver. Metabolism. 1997;46:458–465. doi: 10.1016/S0026-0495(97)90067-6. [DOI] [PubMed] [Google Scholar]
  • 27.Stumvoll M., Chintalapudi U., Perriello G., Welle S., Gutierrez O., Gerich J. Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J. Clin. Investig. 1995;96:2528–2533. doi: 10.1172/JCI118314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Li L., Messina J.L. Acute insulin resistance following injury. Trends Endocrinol. Metab. 2009;20:429–435. doi: 10.1016/j.tem.2009.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Berthet J., Rall T.W., Sutherland E.W. The relationship of epinephrine and glucagon to liver phosphorylase. IV. Effect of epinephrine and glucagon on the reactivation of phosphorylase in liver homogenates. J. Biol. Chem. 1957;224:463–475. [PubMed] [Google Scholar]
  • 30.Walsh D.A., Perkins J.P., Krebs E.G. An adenosine 3‘,5‘-monophosphate-dependant protein kinase from rabbit skeletal muscle. J. Biol. Chem. 1968;243:3763–3765. doi: 10.1016/S0021-9258(19)34204-8. [DOI] [PubMed] [Google Scholar]
  • 31.Studer R.K., Borle A.B. Differences between male and female rats in the regulation of hepatic glycogenolysis. The relative role of calcium and cAMP in phosphorylase activation by catecholamines. J. Biol. Chem. 1982;257:7987–7993. doi: 10.1016/S0021-9258(18)34286-8. [DOI] [PubMed] [Google Scholar]
  • 32.Studer R.K., Snowdowne K.W., Borle A.B. Regulation of hepatic glycogenoylsis by glucagon in male and female rats. Role of cAMP and Ca2+ and interactions between epinephrine and glucagon. J. Biol. Chem. 1984;259:3596–3604. doi: 10.1016/S0021-9258(17)43135-8. [DOI] [PubMed] [Google Scholar]
  • 33.El-Maghrabi M.R., Claus T., Pilkis J., Pilkis S.J. Regulation of 6-phosphfructo-2-kinase activity by cyclic AMP-dependent phosphorylation. Proc. Natl. Acad. Sci. USA. 1982;79:315–319. doi: 10.1073/pnas.79.2.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Richards C.S., Yokoyama M., Furuya E., Uyeda K. Reciprocal changes in fructose-2,6-bisphosphate, 2-kinase and fructose-2,6-bisphosphatase activity in response to glucagon and epinephrine. Biochem. Biophys. Res. Commun. 1982;104:1073–1079. doi: 10.1016/0006-291X(82)91359-6. [DOI] [PubMed] [Google Scholar]
  • 35.Thompson L.H., Kim H.T., Kokorina N.A., Mesina J.L. Acute muscle-type specific insulin resistance following injury. Mol. Med. 2008;14:715–723. doi: 10.2119/2008-00081.Thompson. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 2008;8:923–934. doi: 10.1038/nri2449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wouters M., Posma R.A., van der Weerd L., van Putten T.S., Wendt K.W. Diploma Thesis. ESICM Paris; Paris, France: 2013. Incidence, Causes and Consequences of Early Hypoglycaemia in Severe Trauma Patients. [Google Scholar]
  • 38.Skjelstad T., Sørensen M.A., Nielsen E.W. Alpine cross-country skier with energy depletion and reduced consciousness. Tidsskr. Nor. Legeforen. 2017;137:289–292. doi: 10.4045/tidsskr.16.0267. [DOI] [PubMed] [Google Scholar]
  • 39.Moore E.E., Shackford S.R., Pachter H.L., McAninch J.W., Browner B.D., Champion H.R., Flint L.M., Gennarelli T.A., Malangoni M.A., Ramenofsky M.L. Organ injury scaling: Spleen, liver, and kidney. J. Trauma. 1989;29:1664–1666. doi: 10.1097/00005373-198912000-00013. [DOI] [PubMed] [Google Scholar]
  • 40.Kozar R.A., Crandall M., Shanmuganathan K., Zarzaur B.L., Coburn M., Cribari C., Kaups K., Schuster K., Tominaga G.T., The AAST Patient Assessment Committee Organ injury scaling 2018 update: Spleen, liver, and kidney. J. Trauma Acute Care Surg. 2018;85:1119–1122. doi: 10.1097/TA.0000000000002058. [DOI] [PubMed] [Google Scholar]
  • 41.Morell-Hofert D., Primavesi F., Fodor M., Gassner E., Kranebitter V., Braunwarth E., Haselbacher M., Nitsche U.P., Schmid S., Blauth M., et al. Validation of the revized 2018 AAST-OIS classification and the CT severity index for prediction of operative management and survival in patients with blunt spleen and liver injuries. Eur. Radiol. 2020;30:6570–6581. doi: 10.1007/s00330-020-07061-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Fodor M., Primavesi F., Morell-Hofert D., Kranebitter V., Palaver A., Braunwarth E., Haselbacher M., Nitsche U., Schmid S., Blauth M., et al. Non-operative management of blunt hepatic and splenic injury: A time-trend and outcome analysis over a period of 17 years. World J. Emerg. Surg. 2019;14:29. doi: 10.1186/s13017-019-0249-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Abajas Bustillo R., Leal Costa C., Ortego Mate M.D.C., Zonfrillo M.R., Seguí Gómez M., Durá Ros M.J. Classification of the severe trauma patient with the Abbreviated Injury Scale: Degree of correlation between versions 98 and 2005 (2008 update) Emergencias. 2018;30:41–44. [PubMed] [Google Scholar]
  • 44.Baker S.P., O’Neill B., Haddon W., Jr., Long W.B. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care. J. Trauma. 1974;14:187–196. doi: 10.1097/00005373-197403000-00001. [DOI] [PubMed] [Google Scholar]
  • 45.Yendamuri S., Fulda G.J., Tinkoff G.H. Admission Hyperglycemia as a Prognostic Indicator in Trauma. J. Trauma. 2003;55:33–38. doi: 10.1097/01.TA.0000074434.39928.72. [DOI] [PubMed] [Google Scholar]
  • 46.Laird A.M., Miller P.R., Kilgo P.D., Meredith J.W., Chang M.C. Relationship of early hyperglycemia to mortality in trauma patients. J. Trauma. 2004;56:1058–1062. doi: 10.1097/01.TA.0000123267.39011.9F. [DOI] [PubMed] [Google Scholar]
  • 47.Bochicchio G.V., Salzano L., Joshi M., Bochicchio K., Scalea T.M. Admission preoperative glucose is predictive of morbidity and mortality in trauma patients who require immediate operative intervention. Am. Surg. 2005;71:171–174. doi: 10.1177/000313480507100215. [DOI] [PubMed] [Google Scholar]
  • 48.Kreutziger J., Wenzel V., Kurz A., Constantinescu M.A. Admission blood glucose is an independent predictive factor for hospital mortality in polytraumatised patients. Intensive Care Med. 2009;35:1234–1239. doi: 10.1007/s00134-009-1446-z. [DOI] [PubMed] [Google Scholar]
  • 49.Kreutziger J., Schlaepfer J., Wenzel V., Constantinescu M.A. The role of admission blood glucose in outcome prediction of surviving patients with multiple trauma. J. Trauma. 2009;67:704–708. doi: 10.1097/TA.0b013e3181b22e37. [DOI] [PubMed] [Google Scholar]
  • 50.Rau C.S., Wu S.C., Chen Y.C., Chien P.C., Hsieh H.Y., Kuo P.J., Hsieh C.H. Higher Mortality in Trauma Patients Is Associated with Stress-Induced Hyperglycemia, but Not Diabetic Hyperglycemia: A Cross-Sectional Analysis Based on a Propensity-Score Matching Approach. Int. J. Environ. Res. Public Health. 2017;14:1161. doi: 10.3390/ijerph14101161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Stumvoll M., Meyer C., Perriello G., Kreider M., Welle S., Gerich J. Human Kidney and Liver Gluconeogenesis: Evidence for organ substrate selectivity. Am. J. Physiol. 1998;274:E817–E826. doi: 10.1152/ajpendo.1998.274.5.E817. [DOI] [PubMed] [Google Scholar]
  • 52.Rau C.S., Wu S.C., Chen Y.C., Chien P.C., Hsieh H.Y., Kuo P.J., Hsieh C.H. Stress-Induced Hyperglycemia in Diabetes: A Cross-Sectional Analysis to Explore the Definition Based on the Trauma Registry Data. Int. J. Environ. Res. Public Health. 2017;14:1527. doi: 10.3390/ijerph14121527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kerby J.D., Griffin R.L., MacLennan P., Rue L.W. Stress-Induced Hyperglycemia, Not Diabetic Hyperglycemia, Is Associated with Higher Mortality in Trauma. Ann. Surg. 2012;256:446–452. doi: 10.1097/SLA.0b013e3182654549. [DOI] [PubMed] [Google Scholar]
  • 54.Meyer C., Stumvoll M., Welle S., Woerle H.J., Haymond M., Gerich J. Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans. Am. J. Physiol. Endocrinol. Metab. 2003;285:E819–E826. doi: 10.1152/ajpendo.00145.2003. [DOI] [PubMed] [Google Scholar]
  • 55.Frank S.M., Fleisher L.A., Olson K.F., Gorman R.B., Higgins M.S., Breslow M.J., Sitzmann J.V., Beattie C. Multivariate determinats of early postoperative oxygen consumption in elderly patients. Effects of shivering, body temperature, and gender. Anesthesiology. 1995;83:241–249. doi: 10.1097/00000542-199508000-00002. [DOI] [PubMed] [Google Scholar]
  • 56.Chen J.H., Michiue T., Inamori-Kawamoto O., Ikeda S., Ishikawa T., Maeda H. Comprehensive investigation of postmortem glucose levels in blood and body fluids with regard to the cause of death in forensic autopsy cases. Leg. Med. 2015;17:475–482. doi: 10.1016/j.legalmed.2015.08.004. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data that support the findings of this study are available from the corresponding author upon reasonable request.

Articles from Diagnostics are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES